• Latest Posts
Podcast 16 Jun 2023

Beyond Biotech podcast 50

Kate Therapeutics launches with $51M to develop genetic medicines for muscle and heart diseases

AAVantgarde closes €61M financing to move gene delivery program to the clinic

ElevateBio raises $401M for cell and gene therapies

Novartis buys AVROBIO cystinosis gene therapy program for $87.5M

Rocket Pharmaceuticals receives FDA designation for pyruvate kinase deficiency gene therapy


FDA approves first topical gene therapy for dystrophic epidermolysis bullosa wound treatment

In Depth 19 May 2023

Can cardiovascular diseases be cured? The future of heart treatment

8 rare diseases selected for gene therapy trial portfolio

Sania Therapeutics launches to advance neural circuit dysfunction medicines

Cell and gene therapy company NewBiologix exits stealth with $50M

Delivering on the need for vector innovation in genetic medicine